Two-meter distancing halves risk compared to one meter, suggests a new review

A trial is under way of the first new antibody medicine developed to treat covid-19

Sponsored by Supermicro The Download Your daily dose of what’s up in emerging technology 06.02.20 Good morning! Today: a comprehensive new review suggests we should stick to two-meter distancing, and a trial of the first antibody drug for covid-19 is now underway. Get your friends to sign up here to get The Download every day. Two-meter distancing halves risk compared to one meter, says new review   The news: Keeping people two meters apart from each other is far more effective than just one at reducing the risk of spreading coronavirus, according to a new review in The Lancet. The researchers found that the risk of infection when people stand one meter away is 3%, compared with 13% if standing within a meter. The risk of transmission halves for every extra meter of distancing up to three meters, the modelling suggested. The researchers also found that both face coverings and eye protection significantly reduce the risk of spreading the virus. Why it matters: Governments around the world are discussing how to ensure people’s safety while lifting lockdown restrictions. It’s clear from this peer-reviewed paper that keeping people as physically apart from each other as possible has to be at the core of any sensible strategy. Read the full story. A trial is under way of the first new antibody medicine developed to treat covid-19 The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug will be studied in non-hospitalized coronavirus patients later this summer. The big idea: Researchers used blood drawn from an early survivor of covid-19 in the US back in February, containing the antibodies that lock onto the virus and neutralize it. The goal is to turn one person’s successful immune response to covid-19 into a drug that can benefit everyone. These drugs aren’t vaccines and would not offer permanent immunity. But they could act like a temporary shot, giving people weeks or months of protection. If the trial that has just started is successful, it will be one of the first treatments for covid-19.  Not alone: This particular drug is the result of a collaboration between pharmaceutical giant Eli Lilly and Vancouver-based biotech firm AbCellera. However, others are trying to create their own antibody drugs too. Regeneron and a partnership between GlaxoSmithKline and Vir Biotechnology are both expected to start testing their versions soon.. The wider picture: This drug won’t be a silver bullet. The virus still isn’t that well understood, which makes treating it very difficult. Read the full story. We can still have nice things A place for comfort, fun and distraction in these weird times. (Got any ideas? Drop me a line or tweet 'em at me.)   + There were surprise fireworks in Japan to cheer people up.   + Go on safari from home.  Yesterday I included a link to a website where you can remotely feed chickens (for free!) More than 1,000 of you took me up on the offer. Here’s a message from the chickens’ owner, Cameron Turner: “Refilled the treater 3x before the chickens got too full to eat and had dust baths instead. :) Needless to say, they had a good day being loved by people from all over the world.” And he shared this photo of the chickens looking very satisfied… Sponsor Message Watch Now - Supermicro 5G Live Forum Learn about the latest server and solution innovations for 5G and Telco operators from Supermicro. Our 5G Live Forum event brought together key technologists from Supermicro, Intel®, software partners, and leading international telecom providers to present and discuss the latest solutions and innovations in telecommunications infrastructure from the RAN to the Edge to the Cloud. Watch Now: 1. Supermicro 5G Live Forum – Infrastructure Innovation  2. Partner Showcase: T-Systems EdgAIR Collaboration  3. Partner Showcase: Telefónica Open RAN Initiative  4. Supermicro Solutions for the 5G Micro Data Center  5. Breakout: 5G Core Terabit Traffic Demo  6. Breakout: O-RAN Solution for 5G  7. Breakout: Smart Edge and CERA for Advanced MEC  The top ten must-reads I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology. 1 Police violence will make it harder to fight coronavirus There’s a risk vulnerable communities will be even less likely to trust health officials. (The Verge)   + The battleground is online. (WSJ $)   + Russia and China are trying to sow discord ahead of November’s election. (Politico)   + False claims about a blackout in Washington DC burgeoned on Twitter. (WP $)   + Dallas Police asked for videos of protesters. They got K-Pop instead. (Buzzfeed)   + There are few signs of involvement by outsider extremist groups. (NBC)   + How to protest without sacrificing your privacy. (Vice)  2 ACE2: the enzyme at the center of the covid-19 mystery It could explain why, for example, smokers seem to fare better. (Wired $) 3 Italy has launched a contact tracing app And it’s already facing widespread resistance. (Reuters)   + A new bill in the US would regulate contact tracing apps. (WP $)   4 At-home covid testing is here But how accurate is it? (WSJ $) 5 Facebook employees staged a virtual walkout over Trump posts Zuckerberg has found himself at odds with many of his own staff. (The Guardian) 6 The sun seems to be waking up again ☀️ It’s been relatively dormant for several years. That might be about to change. (Vice) 7 Could animals spread coronavirus? This is what we know so far—but we need a lot more research. (Nature) 8 What if we treated Amazon like it’s a country? After all, it’s richer than many of them. (Tortoise) 9 Universities are scrambling to respond to the pandemic 🎓 Most people don’t want to pay tens of thousands of dollars for a year of Zoom calls. (Wired UK) 10 The latest Spotify scam: faking collaborations with famous artists 🎤 People go to extreme lengths to game the algorithm—and snaffle extra plays. (OneZero) Are you intellectually curious? Tech obsessed?  We are too. Subscribe to MIT Technology Review today for an insightful and discerning look into the technology for the future without getting bogged down by the jargon. Quote of the day “We are really early in this disease. If this were a baseball game, it would be the second inning.” —Dr. Ashish Jha, the director of the Harvard Global Health Institute, delivers a verdict on where we stand to the New York Times. Top image credit: Associated Press Please send full chickens to hi@technologyreview.com. Follow me on Twitter at @charlottejee. Thanks for reading! —Charlotte Was this newsletter forwarded to you, and you'd like to see more? Sign up for free Technologies driving business Virtual conference, June 8–10 *View this in a browser You received this newsletter because you  Webmaster220 Bible Study Blog subscribed with your email address                                *Edit email preferences   |   *Unsubscribe from all emails Follow us: MIT Technology Review One Main Street Cambridge, MA 02142

*the blog owner has deleted the hyperlink intentionally For a treasure box of Spurgeon  here for audio and here for books or audio      Bible Study Material   Receive Free Shipping with code GRACE through 5/31 Bible Study Material from alibris Free shipping info here Affiliate marketer links: Affiliate marketer Rick Livermore with Webmaster220 Bible Study Blog will earn a commission on the Bible Study Material you buy from faith gateway store  and alibris.  Brought to you by Rick Livermore and Webmaster220 Bible Study Blog    If you would like to offset my expenses of producing all this free content, but you want to pass on buying  materials from faith gateway store and alibris, feel free to give a little something-------Give through PayPal-----Rick Livermore-Webmaster220 I live in San Juan Capistrano California now  a fan of  tubitv.com/category/faith_and_spirituality also a fan of tubitv.com/channels/dovechannel  The most important link on this blog is this one about cures to the coronavirus.  Also this one about vaccines that immunize people from catching the coronavirus.  Then there is this one about copper as a weapon to combat this virus. This one could save some lives about the Red Cross. This one is a plasma cure link.